Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants.

Han-Gang YuGina SizemoreIvan MartinezPeter Perrotta

Published in: Biomolecules (2022)

We developed an efficient method to screen FDA-approved ion channel modulators that could be repurposed to detect and inhibit SARS-CoV-2 viral replication, independent of variants.

Keyphrases

sars cov
small molecule
copy number
drug administration
respiratory syndrome coronavirus
high throughput
dna methylation